Vitasora Health Limited
VHLUF
$0.01
-$0.05-91.39%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.88M | 2.43M | 1.99M | 1.40M | 820.40K |
| Total Other Revenue | 359.00K | 378.40K | 404.00K | 404.00K | 404.00K |
| Total Revenue | 3.24M | 2.81M | 2.39M | 1.80M | 1.22M |
| Cost of Revenue | -123.60K | -49.70K | 27.00K | 114.60K | 200.40K |
| Gross Profit | 3.36M | 2.85M | 2.36M | 1.69M | 1.02M |
| SG&A Expenses | 10.28M | 9.45M | 8.67M | 7.26M | 5.91M |
| Depreciation & Amortization | 446.60K | 242.10K | 38.50K | 20.80K | 3.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.70M | 9.77M | 8.89M | 7.53M | 6.22M |
| Operating Income | -7.46M | -6.96M | -6.50M | -5.73M | -5.00M |
| Income Before Tax | -7.46M | -6.96M | -6.50M | -5.73M | -5.00M |
| Income Tax Expenses | 800.00 | 800.00 | 800.00 | 400.00 | -- |
| Earnings from Continuing Operations | -7.46 | -6.96 | -6.50 | -5.73 | -5.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.46M | -6.96M | -6.50M | -5.73M | -5.00M |
| EBIT | -7.46M | -6.96M | -6.50M | -5.73M | -5.00M |
| EBITDA | -7.42M | -6.92M | -6.46M | -5.69M | -4.95M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 6.64B | 6.11B | 5.58B | 5.13B | 4.68B |
| Average Diluted Shares Outstanding | 6.64B | 6.11B | 5.58B | 5.13B | 4.68B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |